Side-by-side comparison of AI visibility scores, market position, and capabilities
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Automated indoor mushroom farm using AI-driven microbiome discovery at 1/3 traditional cost; $4M from YC and Haystack targeting $50B global mushroom market with distributed robotic growing.
Hedgehog is a San Francisco-based agtech company building automated indoor mushroom farms — using AI-powered sensing, robotic growing systems, and an AI-driven microbiome discovery platform to produce mushrooms at less than one-third the cost of traditional mushroom farming, targeting the $50 billion global mushroom industry with a distributed, automated growing model. Founded in 2022 and backed by $4 million from Y Combinator, Shared Future Fund, and Haystack, Hedgehog's 18-person team has developed technology to identify optimal microbiomes that enable fungi growth at 1,000x scale compared to conventional methods.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.